YOUR LENTIVIRUS
SPECIALIZED PARTNER
Lentiviral vector GMP CDMO
DEVELOPMENT AND MANUFACTURING
LENTIVIRAL VECTOR GMP CDMO
Our main aim is to adapt to your own requirements from a technical and timeline perspective
R&D
LENTIVIRAL VECTOR R&D
Our main aim is to implement a technology development strategy focused on providing a response to the main hurdles that currently exist within the gene therapy field
LATEST NEWS
27 April 2021
Report about VIVEbiotech in El Confidencial
26 February 2021
VIVEbiotech finalist of the National SME 2020 Award
CONTACT OUR EXPERTS FOR FURTHER DISCUSSION
